| Synthesis and biological evaluation of 1, 3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors A Zarghi, T Zebardast, F Hakimion, FH Shirazi, PNP Rao, EE Knaus Bioorganic & medicinal chemistry 14 (20), 7044-7050, 2006 | 103 | 2006 |
| Design and synthesis of 3-alkyl-2-aryl-1, 3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors T Zebardast, A Zarghi, B Daraie, M Hedayati, OG Dadrass Bioorganic & medicinal chemistry letters 19 (12), 3162-3165, 2009 | 88 | 2009 |
| Design and synthesis of new 1, 3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors A Zarghi, T Zebardast, B Daraie, M Hedayati Bioorganic & medicinal chemistry 17 (15), 5369-5373, 2009 | 87 | 2009 |
| Remarks in successful cellular investigations for fighting breast cancer using novel synthetic compounds FH Shirazi, A Zarghi, A Ashtarinezhad, F Kobarfard, M Nakhjavani, ... INTECH Open Access Publisher, 2011 | 63 | 2011 |
| Molecular docking and QSAR study of 2-benzoxazolinone, quinazoline and diazocoumarin derivatives as anti-HIV-1 agents K Faghihi, M Safakish, T Zebardast, Z Hajimahdi, A Zarghi Iranian Journal of Pharmaceutical Research: IJPR 18 (3), 1253, 2019 | 18 | 2019 |
| Design and Synthesis of New 1, 3‐Benzdiazinan‐4‐one Derivatives as Selective Cyclooxygenase (COX‐2) Inhibitors A Zarghi, T Zebardast, F Hajighasemali, E Alipoor, B Daraie, M Hedayati Archiv der Pharmazie 345 (4), 257-264, 2012 | 12 | 2012 |
| QSAR modeling of COX-2 inhibitory activity of some dihydropyridine and hydroquinoline derivatives using multiple linear regression (MLR) method S Akbari, T Zebardast, A Zarghi, Z Hajimahdi Iranian Journal of Pharmaceutical Research: IJPR 16 (2), 525, 2017 | 11 | 2017 |
| Remarks in Successful Cellular Investigations for Fighting Breast Cancer Using Novel Synthetic Compounds H Farshad, A Zarghi, F Kobarfard, R Zendehdel, M Nakhjavani, S Arfaiee, ... Breast Cancer—Focusing Tumor Microenvironment, Stem Cells and Metastasis …, 2011 | 5 | 2011 |
| QSAR modeling of aminopeptidase N/CD13 (APN) inhibitory activity of some leucine ureido derivatives by GA-MLR and SW-MLR methods N Faraji, T Zebardast, A Zarghi, Z Hajimahdi Letters in Drug Design & Discovery 14 (12), 1348-1357, 2017 | 3 | 2017 |
| Design, Synthesis and Docking studies of New Quinazolinone Derivatives as Anti-HIV-1 Agents Z Hajimahdi, A Zarghi, T Zebardast, N Mostafavi, S Sharifi, N Karimi, ... Iranian Journal of Pharmaceutical Sciences 18 (1), 55-64, 2022 | 1 | 2022 |
| QSAR Modeling of COX-2 Inhibitory Activity of Thiazinan, Benzthiazinan and Benzdiazinan Derivatives SA Avini, T Zebardast, Z Hajimahdi, A Zarghi International Pharmacy Acta 1 (2), 190-197, 2018 | 1 | 2018 |
| Design, synthesis and In-vitro antitumor evaluation of new 2, 3-diaryl-indenopyrazole and 2, 3-diaryl-benzofuropyrazole derivatives as selective cyclooxygenase (COX-2) inhibitors T Zebardast, A Zarghi, FH Shirazi Research in Pharmaceutical Sciences 7 (5), 526, 2012 | 1 | 2012 |
| Design and Synthesis of Novel Diaryl Oxo Pyrrole Derivative as Selective COX-2 Inhibitors M Pazoki, T Zebardast, S Amidi International Pharmacy Acta 5 (2), 7-7, 2022 | | 2022 |
| Design and Synthesis of New Methyl 1, 2-Diaryl-4-Hydroxy-5-oxo-2, 5-Dihydro-1H-Pyrrole-3-Carboxylate Derivatives as Selective COX-2 Inhibitors M Khalessi, T Zebardast, S Amidi International Pharmacy Acta 5 (2), 6-6, 2022 | | 2022 |
| Design and synthesis of New Methyl4-Hydroxy-1-Alkyl-2-aryl 5-Oxo 2, 5-Dihydropyrrole-3-Carboxylate Derivatives as Selective COX-2 Inhibitors R Ahmadvand, T Zebardast, S Amidi International Pharmacy Acta 5 (2), 8-8, 2022 | | 2022 |
| Design and Synthesis of New Biarylhydrazides Possessing an Azido Pharmacophore as Selective COX-2 Inhibitors T Zebardast, A Zarghi, H Salehiniya JOURNAL OF PHARMACEUTICAL & HEALTH SCIENCES 1 (4), 67-72, 2012 | | 2012 |
| Design, synthesis and biological evaluation of chalcone derivatives possessing a methanesulfonamido pharmacophore as selective COX-2 inhibitors T Zebardast, A Zarghi JOURNAL OF PHARMACY AND PHARMACOLOGY 59, A48-A49, 2007 | | 2007 |
